Regulatory bodies such as the World Health Organization (WHO) and National Institutes of Health (NIH) play a crucial role in setting guidelines for IP management in epidemiology. These organizations often provide frameworks for balancing innovation with public health needs. Compliance with these guidelines ensures that IP practices contribute positively to global health.
